BACKGROUND: This study employed a convolutional neural network (CNN) to analyze computed tomography (CT) scans with the aim of differentiating among renal tumors according to histologic sub-type.
BACKGROUND: To develop and test the performance of a fully automated system for classifying renal tumor subtypes via deep machine learning for automated segmentation and classification.
Journal of cancer research and clinical oncology
Sep 6, 2023
PURPOSE: There are undetectable levels of fat in fat-poor angiomyolipoma. Thus, it is often misdiagnosed as renal cell carcinoma. We aimed to develop and evaluate a multichannel deep learning model for differentiating fat-poor angiomyolipoma (fp-AML)...
To compare the safety and effectiveness of robot-assisted partial nephrectomy (RAPN) laparoscopic partial nephrectomy (LPN) in the treatment of central renal angiomyolipomas (AMLs). We retrospectively analyzed the clinical data of 103 patients who...
BACKGROUND: Prediction of complications and surgical outcomes is of outmost importance even in patients with benign renal masses. The aim of our study is to test the PADUA, SPARE and R.E.N.A.L. scores to predict nephron sparing surgery (NSS) outcomes...
OBJECTIVE: Establish a workflow that utilizes convolutional neural nets (CNN) to classify solid, lipid-poor, contrast enhancing renal masses using multiphase contrast enhanced CT (CECT) images and to assess the performance of the resulting network.
OBJECTIVES: To develop a deep learning-based method for automated classification of renal cell carcinoma (RCC) from benign solid renal masses using contrast-enhanced computed tomography (CECT) images.
OBJECTIVE: To investigate the discriminative capabilities of different machine learning-based classification models on the differentiation of small (< 4 cm) renal angiomyolipoma without visible fat (AMLwvf) and renal cell carcinoma (RCC).
The question of whether ultrasound point shear wave elastography can differentiate renal cell carcinoma (RCC) from angiomyolipoma (AML) is controversial. This study prospectively enrolled 51 patients with 52 renal tumors (42 RCCs, 10 AMLs). We obtain...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.